Medical device company AngioScore Inc. said Wednesday it raised $12 million in private equity financing.
Fremont-based AngioScore has received regulatory clearance to market both coronary and peripheral AngioSculpt catheters in the U.S., Europe and Japan.
The round was led by San Francisco-based Saints Capital.
No comments:
Post a Comment